NDC 51662-1448

LEXISCAN(R) (REGADENOSON)

Lexiscan(r) (regadenoson)

LEXISCAN(R) (REGADENOSON) is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Regadenoson.

Product ID51662-1448_99640071-4db3-9317-e053-2995a90a610d
NDC51662-1448
Product TypeHuman Prescription Drug
Proprietary NameLEXISCAN(R) (REGADENOSON)
Generic NameLexiscan(r) (regadenoson)
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2019-12-10
Marketing CategoryNDA / NDA
Application NumberNDA022161
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameREGADENOSON
Active Ingredient Strength0 mg/mL
Pharm ClassesAdenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 51662-1448-1

1 SYRINGE, PLASTIC in 1 CARTON (51662-1448-1) > 5 mL in 1 SYRINGE, PLASTIC
Marketing Start Date2019-12-10
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
REGADENOSON.08 mg/mL

Pharmacological Class

  • Adenosine Receptor Agonist [EPC]
  • Adenosine Receptor Agonists [MoA]

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.